355 related articles for article (PubMed ID: 7584112)
21. Inhibition of HIV-1 replication by an anti-tat hammerhead ribozyme.
Jackson WH; Moscoso H; Nechtman JF; Galileo DS; Garver FA; Lanclos KD
Biochem Biophys Res Commun; 1998 Apr; 245(1):81-4. PubMed ID: 9535787
[TBL] [Abstract][Full Text] [Related]
22. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
[TBL] [Abstract][Full Text] [Related]
23. Anti-termination by SIV Tat requires flexibility of the nascent TAR structure.
Sommer P; Vartanian JP; Wachsmuth M; Henry M; Guetard D; Wain-Hobson S
J Mol Biol; 2004 Nov; 344(1):11-28. PubMed ID: 15504399
[TBL] [Abstract][Full Text] [Related]
24. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U; Böhnlein E; Veres G
Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of site-specifically modified oligoribonucleotides for studies of the recognition of TAR RNA by HIV-1 tat protein and studies of hammerhead ribozymes.
Slim G; Pritchard C; Biala E; Asseline U; Gait MJ
Nucleic Acids Symp Ser; 1991; (24):55-8. PubMed ID: 1841380
[TBL] [Abstract][Full Text] [Related]
27. Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1.
Yamada O; Yu M; Yee JK; Kraus G; Looney D; Wong-Staal F
Gene Ther; 1994 Jan; 1(1):38-45. PubMed ID: 7584058
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
Lisziewicz J; Sun D; Smythe J; Lusso P; Lori F; Louie A; Markham P; Rossi J; Reitz M; Gallo RC
Proc Natl Acad Sci U S A; 1993 Sep; 90(17):8000-4. PubMed ID: 8367455
[TBL] [Abstract][Full Text] [Related]
29. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
Liu J; Woffendin C; Yang ZY; Nabel GJ
Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
[TBL] [Abstract][Full Text] [Related]
30. Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule.
Cagnon L; Cucchiarini M; Lefebvre JC; Doglio A
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):349-58. PubMed ID: 7541291
[TBL] [Abstract][Full Text] [Related]
31. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation.
Sullenger BA; Gallardo HF; Ungers GE; Gilboa E
J Virol; 1991 Dec; 65(12):6811-6. PubMed ID: 1942253
[TBL] [Abstract][Full Text] [Related]
32. Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.
Konopka K; Düzgüneş N; Rossi J; Lee NS
J Drug Target; 1998; 5(4):247-59. PubMed ID: 9713975
[TBL] [Abstract][Full Text] [Related]
33. A new reporter system for detection of retroviral infection.
Planelles V; Haislip A; Withers-Ward ES; Stewart SA; Xie Y; Shah NP; Chen IS
Gene Ther; 1995 Aug; 2(6):369-76. PubMed ID: 7584111
[TBL] [Abstract][Full Text] [Related]
34. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
[TBL] [Abstract][Full Text] [Related]
36. Expression of the human immunodeficiency virus type 1 primer binding sequence inhibits HIV-1 replication.
Kechli AM; Freiden PJ; Rossi JJ; Brenner MK; Choueiry MA; Garcia JV; Slobod KS
Hum Gene Ther; 1998 Mar; 9(4):587-90. PubMed ID: 9525319
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication.
Sullenger BA; Gallardo HF; Ungers GE; Gilboa E
Cell; 1990 Nov; 63(3):601-8. PubMed ID: 2225067
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of transcription by the TAR RNA of HIV-1 in a nuclear extract of HeLa cells.
Yamamoto R; Koseki S; Ohkawa J; Murakami K; Nishikawa S; Taira K; Kumar PK
Nucleic Acids Res; 1997 Sep; 25(17):3445-50. PubMed ID: 9254702
[TBL] [Abstract][Full Text] [Related]
39. Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.
Veres G; Junker U; Baker J; Barske C; Kalfoglou C; Ilves H; Escaich S; Kaneshima H; Böhnlein E
J Virol; 1998 Mar; 72(3):1894-901. PubMed ID: 9499041
[TBL] [Abstract][Full Text] [Related]
40. Effective suppression of HIV-1 gene expression by a mammalian tRNA 3' processing endoribonuclease and external guide sequence oligozymes.
Kitano M; Barnor JS; Miyano-Kurosaki N; Endo Y; Yukita M; Takeuchi H; Tamura Y; Takai K; Nashimoto M; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):719-22. PubMed ID: 11563100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
